China

BMI View: Sourcing accurate and reliable quantitative data from emerging pharmaceutical markets remains challenging. Both primary and secondary research firms are faced with sub-standard... 2010-07-14

BMI Core View: Sales forces will contract in developed states and expand in emerging markets. The primary cause of this trend is the declining influence of US and Western European doctors... 2010-06-17

BMI Core View: Drugmakers will increasingly use differential pricing in emerging markets. Pharmaceutical companies generally price their patented medicines at the maximum the market... 2010-05-07

BMI View: China's pharmaceutical market is more attractive to Western firms than India's. Absolute spending on medicines is higher (US$45.5bn in China versus US$17.1bn in India) and... 2010-05-04

Basel-based multinational Novartis is to expand its sales team and build its research capabilities in China, according to CEO Joe Jimenez. The former tactic will boost sales immediately,... 2010-04-30

BMI View: China has the world's most attractive emerging pharmaceutical market. Driven by a booming economy, sales of prescription drugs and over-the-counter (OTC) medicines are forecast... 2010-04-28

US-based clinical research organisation (CRO) Charles River Laboratories has acquired laboratory services firm WuXi PharmaTech for US$1.6bn in cash and stock. BMI expects the combined... 2010-04-27